| Breakdown | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 736.40B | 619.59B | 564.49B | 536.02B | 507.86B |
| Gross Profit | 189.02B | 161.47B | 147.83B | 140.45B | 133.98B |
| EBITDA | 47.87B | 41.98B | 38.36B | 36.35B | 33.68B |
| Net Income | 20.18B | 18.24B | 15.85B | 15.38B | 14.59B |
Balance Sheet | |||||
| Total Assets | 376.21B | 342.41B | 318.23B | 306.00B | 269.12B |
| Cash, Cash Equivalents and Short-Term Investments | 50.23B | 48.18B | 45.78B | 31.27B | 32.08B |
| Total Debt | 80.85B | 77.60B | 93.22B | 97.25B | 77.04B |
| Total Liabilities | 190.27B | 174.50B | 176.61B | 177.16B | 152.50B |
| Stockholders Equity | 181.10B | 167.90B | 141.61B | 128.83B | 116.63B |
Cash Flow | |||||
| Free Cash Flow | 7.38B | 13.46B | 13.60B | -8.30B | 5.78B |
| Operating Cash Flow | 43.18B | 37.16B | 33.28B | 30.52B | 26.90B |
| Investing Cash Flow | -37.01B | -26.79B | -10.52B | -46.91B | -23.34B |
| Financing Cash Flow | -5.75B | -8.07B | -8.25B | 15.57B | 4.19B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
77 Outperform | ¥112.31B | 8.65 | ― | 2.53% | 5.57% | 27.41% | |
67 Neutral | ¥391.49B | 9.01 | ― | 1.55% | ― | ― | |
64 Neutral | ¥5.35B | -11.32 | ― | 1.33% | -3.57% | 33.78% | |
60 Neutral | ¥1.99B | -14.74 | ― | ― | -3.35% | -63.96% | |
57 Neutral | ¥194.35B | 8.93 | ― | 1.44% | 1.48% | -33.32% | |
57 Neutral | $3.13B | 9.23 | -34.32% | 3.14% | -25.56% | -353.61% | |
39 Underperform | ¥2.07B | -66.85 | ― | ― | -6.41% | 51.66% |